Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL INSTITUTES OF HEALTH NIDA

Contract Value

Not provided

Codes & Classification
Solicitation Number

75N98026R00175

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Classification Code

AN11

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has issued a Sources Sought Notice (No. 75N98026R00175) to gather information from qualified organizations regarding their capabilities to provide comprehensive biobanking, laboratory analytics, and associated informatics services in support of NIH biorepositories. This notice is intended solely for market research and planning purposes; it is not a solicitation for proposals or quotations, nor does it commit the government to any future procurement action. **Purpose and Scope** The primary objective of this market research is to identify capable R&D firms, small businesses, and potential subcontractors that can support the operation, consolidation, and/or recompete of one or more NIH-funded biorepositories for Fiscal Year 2028. At a minimum, this includes the NIDA Center for Genetic Studies (NCGS), the NIH Brain Development Cohorts (NBDC) Biobank—which supports the Adolescent Brain Cognitive Development (ABCD) Study—and the HEALthy Brain and Child Development (HBCD) Study. NIH currently manages over 20 biorepositories across more than 10 Institutes and Centers, collectively storing millions of biospecimens and associated data to advance research into health, development, and disease. **Key Requirements and Expected Deliverables** Respondents must demonstrate extensive experience and technical capability across several core areas: 1. **Sample Management and Storage** - Secure, humidity- and temperature-controlled storage and tracking for at least 3.5 million biospecimens, adhering to Best Practices, Clinical and Laboratory Standards, and Good Laboratory Practice (GLP; 21 CFR 58). - Capacity for expansion beyond the minimum storage requirement. - Chain of custody management, discrepancy resolution, and regulatory-compliant sample destruction. - Centralized, cost-effective distribution of biosamples to qualified investigators. - Provision of collection kits, barcoded supplies, and training for research staff. 2. **Data Curation and Management** - Development and maintenance of SOPs for all aspects of sample handling. - Receipt and management of de-identified clinical, diagnostic, environmental, and phenotypic data. - Maintenance of an internal relational database (e.g., with RRIDs) and auditable Laboratory Information Management System (LIMS). - Data cleaning, standardization, and harmonization across diagnostic systems (e.g., RDOC, DSM, ICD). - Transfer of data and sample IDs to controlled-access repositories or data centers. 3. **Laboratory and Analytic Capabilities** - Laboratory expertise in molecular biology, quality control, tissue/cell culture, and CLIA certification. - Capabilities for a range of assays and advanced techniques, including high-throughput genotyping, sequencing, proteomics, metabolomics, iPSC/neural stem cell line generation, CRISPR/Cas9 gene editing, and analysis of FFPE tissue. - Scientific and technical support for researcher requests and biospecimen availability. - Experience in biobanking, LIMS, and database management. 4. **Informatics and Cyberinfrastructure** - Development and enhancement of biorepository web portals, including public- and investigator-facing tools. - Backend infrastructure management (e.g., server maintenance, relational databases), front-end design, and UI/UX. - Maintenance of Authority to Operate (ATO) and compliance with FISMA and NIH security requirements. - Development and maintenance of APIs and secure, interoperable data exchange infrastructure. - Capabilities for homomorphic encryption and distributed learning. 5. **Collaboration and Governance** - Strong collaborative relationships with NIH Data Centers, study teams, and Institutes/Centers. - Participation as a co-signatory on Specimen/Material Transfer Agreements. - Eligibility for a Certificate of Confidentiality and compliance with all human subjects protection, privacy, and data security regulations. **Contracting Entity and Classification** - **Contracting Entity:** National Institutes of Health (NIH), NIDA - **Department:** U.S. Department of Health and Human Services - **NAICS Code:** 541714 – Research and Development in Biotechnology (except Nanobiotechnology), with a size standard of 1,000 employees or fewer. - **Product Service Code:** AN11 **Submission and Contact Information** Interested organizations must submit a detailed capability statement that addresses their experience, personnel qualifications, and facilities relevant to the requirements outlined above. Submissions should also include company information, point of contact, SAM.gov UEI, NAICS code(s), business size/status, and any applicable socioeconomic designations (e.g., small, veteran-owned, 8(a), HUBZone). - **Primary Contact:** Shaun Rostad, Contract Specialist ([email protected], 301-594-9516) - **Secondary Contact:** Joshua T. Lazarus, Contract Specialist ([email protected]) - **Submission Deadline:** October 20, 2026, by 1:00 p.m. EST - **Submission Method:** Electronic only; paper or faxed statements will not be accepted. - **Notice URL:** [SAM.gov Opportunity](https://sam.gov/opp/2027a59185b1406eaee932909972f3d7/view) **Special Considerations** - This is a Sources Sought Notice, not a request for proposals. No contract will be awarded based on responses to this notice. - The government is particularly interested in identifying small business and socioeconomic set-aside possibilities. - The requirement is currently assessed as non-commercial under FAR 2.101; however, vendors may submit justification if they believe the services qualify as commercial. - Respondents may propose teaming arrangements or identify subcontractors to address all technical requirements. **Constant Elements Over Contract Lifecycle** The core requirements for secure, large-scale biobanking, rigorous laboratory analytics, robust informatics infrastructure, and strict compliance with regulatory and ethical standards will remain central throughout the contract lifecycle. The need for collaboration with NIH entities, adaptability to evolving study needs, and maintenance of high-quality data and sample management practices are also enduring expectations. This opportunity is well-suited for organizations with demonstrated expertise in biorepository operations, advanced laboratory and informatics capabilities, and a strong track record of supporting large-scale biomedical research initiatives in compliance with federal standards.